Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.23B |
| 2 |
Uber
UBER
|
+$514M |
| 3 |
Walt Disney
DIS
|
+$475M |
| 4 |
Analog Devices
ADI
|
+$469M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$391M |
Top Sells
| 1 |
Amazon
AMZN
|
+$1.58B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$434M |
| 4 |
JPMorgan Chase
JPM
|
+$415M |
| 5 |
Morgan Stanley
MS
|
+$397M |
Sector Composition
| 1 | Technology | 15.82% |
| 2 | Healthcare | 13.61% |
| 3 | Industrials | 8.61% |
| 4 | Financials | 8.49% |
| 5 | Consumer Discretionary | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1576
Atara Biotherapeutics
ATRA
$85.1M
| $5.39M | ﹤0.01% |
10,984
-7,421
| -40% | -$3.64M |
|
1577
SiriusXM
SIRI
$7.84B
| $5.38M | ﹤0.01% |
84,460
-833,844
| -91% | -$53.1M |
|
1578
ARK Fintech Innovation ETF
ARKF
$1.37B
| $5.38M | ﹤0.01% |
108,164
+102,524
| +1,818% | +$5.1M |
|
1579
Valvoline
VVV
$5.14B
| $5.37M | ﹤0.01% |
232,012
-399,611
| -63% | -$9.25M |
|
1580
Esperion Therapeutics
ESPR
$573M
| $5.37M | ﹤0.01% |
206,374
+170,207
| +471% | +$4.42M |
|
|
CFACU
1581
DELISTED
CF Finance Acquisition Corp. III Unit
CFACU
| $5.37M | ﹤0.01% |
+500,000
| New | +$5.37M |
|
|
AMRS
1582
DELISTED
Amyris Inc.
AMRS
| $5.36M | ﹤0.01% |
868,726
+702,252
| +422% | +$4.34M |
|
1583
SPDR S&P Insurance ETF
KIE
$829M
| $5.35M | ﹤0.01% |
159,329
-32,321
| -17% | -$1.09M |
|
1584
Ternium
TX
$6.8B
| $5.35M | ﹤0.01% |
183,944
+18,902
| +11% | +$550K |
|
1585
Goldman Sachs ActiveBeta Japan Equity ETF
GSJY
$63.6M
| $5.35M | ﹤0.01% |
143,584
-10,602
| -7% | -$395K |
|
|
OYST
1586
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
| $5.31M | ﹤0.01% |
282,206
+5,000
| +2% | +$94.1K |
|
|
ACB
1587
Aurora Cannabis
ACB
$277M
| $5.3M | ﹤0.01% |
63,810
+11,553
| +22% | +$960K |
|
|
VNE
1588
DELISTED
Veoneer, Inc.
VNE
| $5.3M | ﹤0.01% |
248,768
+48,699
| +24% | +$1.04M |
|
1589
Sally Beauty Holdings
SBH
$1.48B
| $5.3M | ﹤0.01% |
406,103
+162,854
| +67% | +$2.12M |
|
|
JBTM
1590
JBT Marel Corporation
JBTM
$7.14B
| $5.27M | ﹤0.01% |
46,302
+7,426
| +19% | +$846K |
|
1591
McCormick & Company Non-Voting
MKC
$18.5B
| $5.26M | ﹤0.01% |
+55,010
| New | +$5.26M |
|
1592
ePlus
PLUS
$1.97B
| $5.26M | ﹤0.01% |
119,480
-12,756
| -10% | -$561K |
|
1593
iShares MSCI USA Momentum Factor ETF
MTUM
$18.8B
| $5.25M | ﹤0.01% |
+32,520
| New | +$5.25M |
|
1594
Trip.com Group
TCOM
$48.3B
| $5.24M | ﹤0.01% |
155,400
-290,558
| -65% | -$9.8M |
|
1595
Alamos Gold
AGI
$13.9B
| $5.24M | ﹤0.01% |
598,675
-215,605
| -26% | -$1.89M |
|
|
PHICU
1596
DELISTED
Population Health Investment Co., Inc. Unit
PHICU
| $5.23M | ﹤0.01% |
+500,000
| New | +$5.23M |
|
1597
First Trust Preferred Securities and Income ETF
FPE
$6.2B
| $5.22M | ﹤0.01% |
+258,448
| New | +$5.22M |
|
1598
Innovator US Equity Buffer ETF September
BSEP
$188M
| $5.22M | ﹤0.01% |
179,042
+158,684
| +779% | +$4.62M |
|
1599
Community Health Systems
CYH
$412M
| $5.22M | ﹤0.01% |
702,078
+649,478
| +1,235% | +$4.83M |
|
|
INZY
1600
DELISTED
Inozyme Pharma
INZY
| $5.21M | ﹤0.01% |
252,542
+11,464
| +5% | +$237K |
|